Rett syndrome with and without detected MECP2 mutations: an attempt to redefine phenotypes

Brain & Development
Teresa TemudoPatricia Maciel

Abstract

The diagnosis of Rett syndrome (RTT) is based on a set of clinical criteria, irrespective of mutation status. The aims of this study were (1) to define the clinical differences existing between patients with Rett syndrome with (Group I) and without a MECP2 mutation (Group II), and (2) to characterize the phenotypes associated with the more common MECP2 mutations. We analyzed 87 patients fulfilling the clinical criteria for RTT. All were observed and videotaped by the same paediatric neurologist. Seven common mutations were considered separately, and associated clinical features analysed. Comparing Group I and II, we found differences concerning psychomotor development prior to onset, acquisition of propositive manipulation and language, and evolving autistic traits. Based on age at observation, we found differences in eye pointing, microcephaly, growth, number of stereotypies, rigidity, ataxia and ataxic-rigid gait, and severity score. Patients with truncating differed from those with missense mutations regarding acquisition of propositive words and independent gait, before the beginning of the disease, and microcephaly, growth, foot length, dystonia, rigidity and severity score, at the time of observation. Patients with the R1...Continue Reading

References

Jul 1, 1994·Pediatric Neurology·B A Hagberg, O H Skjeldal
May 18, 2000·Human Molecular Genetics·P HuppkeF Hanefeld
Jan 20, 2004·Journal of Medical Genetics·L ColvinJ Christodoulou
Jan 4, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Laila RobertsonHelen Leonard

❮ Previous
Next ❯

Citations

May 19, 2011·Nature Reviews. Neurology·Sakkubai Naidu, Michael V Johnston
Mar 13, 2014·Neuromolecular Medicine·Vichithra R B Liyanage, Mojgan Rastegar
Nov 29, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Minh Vu Chuong NguyenNurit Ballas
Jul 5, 2012·Annals of the New York Academy of Sciences·Claudio De FeliceJoussef Hayek
Dec 6, 2011·American Journal of Medical Genetics. Part a·Aglaia VignoliMaria Paola Canevini
Aug 5, 2015·Revista chilena de pediatría·Gretta Pantaleón F, Tamara Juvier R
May 3, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Cinzia SignoriniJoussef Hayek
Jul 15, 2015·Research in Developmental Disabilities·Gillian S TownendPeter B Marschik
Jul 3, 2013·The Journal of Molecular Diagnostics : JMD·Hiart MaortuaMaría-Isabel Tejada
Aug 21, 2020·Parkinsonism & Related Disorders·Francesca MagrinelliKailash P Bhatia
Nov 18, 2018·Neurobiology of Learning and Memory·Hua YangZhaolan Joe Zhou
Sep 3, 2021·Psychiatry and Clinical Neurosciences·Jatinder SinghParamala Santosh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.